Who owns VISTAGEN THERAPEUTICS ORD?
- Ticker: VTGN
- CUSIP Number: 92840h400
Tip: Access positions for across all investors
Analyze quarterly positions in Vistagen Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vistagen Therapeutics Ord stock
Who bought or sold VISTAGEN THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 4.2M | $15M | 100% | Sep 2025 |
|
| OrbiMed Advisors | 3.1M | $11M | 100% | Sep 2025 |
|
| TCG Crossover Management | 2.7M | $9.5M | 0% | Sep 2025 |
|
| Stempoint Capital | 2.5M | $8.8M | 3% | Sep 2025 |
|
| Nantahala Capital Management | 2.0M | $7.0M | 0% | Sep 2025 |
|
| Vanguard Group | 1.7M | $6.0M | -4% | Sep 2025 |
|
| Commodore Capital | 1.6M | $5.6M | 0% | Sep 2025 |
|
| Ikarian Capital | 621k | $2.2M | 3% | Sep 2025 |
|
| Soleus Capital Management | 550k | $2.0M | 100% | Sep 2025 |
|
| Citadel Advisors | 464k | $1.6M | 351% | Sep 2025 |
|
| Diadema Partners | 450k | $1.6M | 100% | Sep 2025 |
|
| BlackRock | 423k | $1.5M | 1% | Sep 2025 |
|
| Renaissance Technologies | 422k | $1.5M | 942% | Sep 2025 |
|
| Susquehanna International | 331k | $1.2M | 187% | Sep 2025 |
|
| Jane Street | 317k | $1.1M | 234% | Sep 2025 |
|
| Geode Capital Management | 298k | $1.1M | 9% | Sep 2025 |
|
| Two Sigma Investments | 289k | $1.0M | 224% | Sep 2025 |
|
| Jpmorgan Chase & Co | 272k | $965k | -64% | Sep 2025 |
|
| Almitas Capital | 261k | $928k | 0% | Sep 2025 |
|
| AdvisorShares Investments | 207k | $735k | 2% | Sep 2025 |
|
| Boothbay Fund Management | 197k | $699k | 11% | Sep 2025 |
|
| Two Sigma Advisers | 157k | $558k | 508% | Sep 2025 |
|
| BML Capital Management | 150k | $533k | 0% | Sep 2025 |
|
| ADAR1 Capital Management | 113k | $401k | -73% | Sep 2025 |
|
| State Street Corporation | 97k | $344k | 0% | Sep 2025 |
|
| XTX Topco | 70k | $248k | 100% | Sep 2025 |
|
| Dimensional Fund Advisors | 68k | $242k | 57% | Sep 2025 |
|
| Walleye Trading Advisors | 68k | $241k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 60k | $214k | 100% | Sep 2025 |
|
| Northern Trust | 48k | $171k | 0% | Sep 2025 |
|
| Cubist Systematic Strategies | 44k | $156k | 100% | Sep 2025 |
|
| Occudo Quantitative Strategies | 43k | $152k | 100% | Sep 2025 |
|
| American Century Companies | 41k | $146k | 32% | Sep 2025 |
|
| GSA Capital Partners | 32k | $112k | 100% | Sep 2025 |
|
| Group One Trading | 29k | $103k | 305% | Sep 2025 |
|
| UBS Group | 26k | $91k | 13% | Sep 2025 |
|
| Charles Schwab Investment Management | 23k | $83k | 0% | Sep 2025 |
|
| HighTower Advisors | 21k | $74k | 0% | Sep 2025 |
|
| Millennium Management | 21k | $73k | 100% | Sep 2025 |
|
| Kestra Advisory Services | 20k | $71k | 0% | Sep 2025 |
|
| William Blair $ Company | 13k | $45k | -85% | Sep 2025 |
|
| Morgan Stanley | 12k | $24k | 100% | Jun 2025 |
|
| Schonfeld Strategic Advisors | 11k | $39k | 100% | Sep 2025 |
|
| Truvestments Capital | 8.7k | $31k | 21% | Sep 2025 |
|
| FNY Investment Advisers | 6.0k | $21k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 4.1k | $15k | -9% | Sep 2025 |
|
| Performa | 1.0k | $3.6k | 0% | Sep 2025 |
|
| CWM | 582.00 | $2.0k | 0% | Sep 2025 |
|
| MAI Wealth Advisors | 526.00 | $1.9k | 0% | Sep 2025 |
|
| SBI Securities | 290.00 | $1.0k | 1% | Sep 2025 |
|
| Jones Financial Companies, L.L | 114.00 | $401.998200 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 56.00 | $199.001600 | -88% | Sep 2025 |
|
| Fairman Group | 29.00 | $102.999300 | 0% | Sep 2025 |
|
| Barclays | 1.00 | $4.000000 | 0% | Sep 2025 |
|
Who sold out of Vistagen Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sphera Funds Management | Jun 2025 | 448k | $896k |
| Marshall Wace | Jun 2025 | 35k | $69k |
| Virtu Financial | Jun 2025 | 23k | $46k |
| Simplex Trading | Jun 2025 | 23k | $45k |
| Tower Research Capital | Jun 2025 | 7.7k | $15k |
| Raymond James Financial | Jun 2025 | 6.4k | $13k |
| Royal Bank of Canada | Jun 2025 | 3.3k | $7.0k |